NO964486L - Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering - Google Patents

Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering

Info

Publication number
NO964486L
NO964486L NO964486A NO964486A NO964486L NO 964486 L NO964486 L NO 964486L NO 964486 A NO964486 A NO 964486A NO 964486 A NO964486 A NO 964486A NO 964486 L NO964486 L NO 964486L
Authority
NO
Norway
Prior art keywords
prosthesis
acid derivatives
migration
pct
bisphosphonic acid
Prior art date
Application number
NO964486A
Other languages
English (en)
Other versions
NO964486D0 (no
NO310057B1 (no
Inventor
Allen E Goodship
John Kenwright
Jonathan Green
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO964486D0 publication Critical patent/NO964486D0/no
Publication of NO964486L publication Critical patent/NO964486L/no
Publication of NO310057B1 publication Critical patent/NO310057B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
NO964486A 1994-05-04 1996-10-22 Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering NO310057B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408775A GB9408775D0 (en) 1994-05-04 1994-05-04 Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
PCT/IB1995/000288 WO1995030421A1 (en) 1994-05-04 1995-04-24 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Publications (3)

Publication Number Publication Date
NO964486D0 NO964486D0 (no) 1996-10-22
NO964486L true NO964486L (no) 1996-10-22
NO310057B1 NO310057B1 (no) 2001-05-14

Family

ID=10754497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964486A NO310057B1 (no) 1994-05-04 1996-10-22 Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering

Country Status (18)

Country Link
US (1) US5965547A (no)
EP (1) EP0758241B1 (no)
JP (1) JPH09512816A (no)
AT (1) ATE218350T1 (no)
AU (1) AU693541B2 (no)
DE (1) DE69526937T2 (no)
DK (1) DK0758241T3 (no)
ES (1) ES2177642T3 (no)
FI (1) FI118590B (no)
GB (1) GB9408775D0 (no)
HU (1) HUT74984A (no)
IL (1) IL113566A (no)
NO (1) NO310057B1 (no)
NZ (1) NZ283430A (no)
PT (1) PT758241E (no)
TW (1) TW458779B (no)
WO (1) WO1995030421A1 (no)
ZA (1) ZA953537B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
US6137012A (en) 1998-10-13 2000-10-24 E. I. Du Pont De Nemours And Company Phosphole and diphosphole ligands for catalysis
BR9915927A (pt) 1998-12-04 2001-08-21 Roche Diagnostics Gmbh Uso de ácido ibandrÈnico ou seus sais ou ésteres fisiologicamente compatìveis
EP1150684A4 (en) * 1999-02-09 2005-06-15 Sloan Kettering Institutefor C BONE CEMENT ANTI-RESORPTION AND ALLOGENOUS BONE IMPLANTS, AUTOGRAFTS AND XENOGRAFTS
EP1118328A1 (en) * 1999-08-02 2001-07-25 Toray Industries, Inc. Insertion stabilizers for implants
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
SK287278B6 (sk) * 2000-06-20 2010-05-07 Novartis Ag Použitie kyseliny 1-hydroxy-2-(imidazol-1-yl)etán-1,1- difosfónovej na prípravu liečiva na liečenie stavov abnormálne zvýšeného kostného obratu
SI1591122T1 (sl) 2000-06-20 2013-02-28 Novartis Ag Postopek za aplikacijo bisfosfonatov
WO2002004038A1 (en) * 2000-07-12 2002-01-17 Hopital Orthopedique De La Suisse Romande Active biocoating for bone implant
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
KR20120065435A (ko) * 2002-05-10 2012-06-20 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
PT1542700E (pt) * 2002-09-16 2012-02-01 Novartis Ag Método para prevenir ou reduzir fracturas secundárias após a fractura da anca
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
AU2007321109A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
EP1958649A1 (en) * 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
US20100144679A1 (en) * 2007-03-21 2010-06-10 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
WO2008152518A2 (en) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of risedronic acid or risedronate sodium
HUE025737T2 (en) 2009-09-01 2016-05-30 Univ Duke Bisphosphonate compositions and methods for treating heart failure
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
CA2856030A1 (en) 2011-11-16 2013-05-23 Duke University Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
ES2038692T4 (es) * 1986-11-21 2012-02-10 Novartis Ag Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices

Also Published As

Publication number Publication date
DE69526937T2 (de) 2003-01-02
FI964332A0 (fi) 1996-10-28
IL113566A (en) 2002-05-23
AU2146695A (en) 1995-11-29
NZ283430A (en) 2000-06-23
HU9603042D0 (en) 1997-01-28
HUT74984A (en) 1997-03-28
TW458779B (en) 2001-10-11
JPH09512816A (ja) 1997-12-22
US5965547A (en) 1999-10-12
NO964486D0 (no) 1996-10-22
ZA953537B (en) 1995-11-06
ATE218350T1 (de) 2002-06-15
FI964332A (fi) 1996-10-28
AU693541B2 (en) 1998-07-02
EP0758241B1 (en) 2002-06-05
WO1995030421A1 (en) 1995-11-16
ES2177642T3 (es) 2002-12-16
GB9408775D0 (en) 1994-06-22
PT758241E (pt) 2002-10-31
IL113566A0 (en) 1995-08-31
FI118590B (fi) 2008-01-15
EP0758241A1 (en) 1997-02-19
NO310057B1 (no) 2001-05-14
DE69526937D1 (de) 2002-07-11
DK0758241T3 (da) 2002-09-23

Similar Documents

Publication Publication Date Title
NO964486L (no) Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
NO952229D0 (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
IL116083A0 (en) Liquid pharmaceutical compositions containing ondansetron and their use
ATE141792T1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson- syndromen
PL309604A1 (en) Pharmaceutical composition for treating nicotin dependence
AU7500794A (en) Novel use of dexmedetomidine
NZ331953A (en) Benzopyran derivatives having leukotriene-antagonistic action
ZA974387B (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
ZA9427B (en) Use of riluzole for promoting restoration following radiation
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees